Gene Biotherapeutics, Inc. License Agreements
11 Contracts & Agreements
- License and Patent Assignment Agreement dated April 10, 2020 between Activation Therapeutics, Inc. and Shanxi Taxus Pharmaceuticals Co., Ltd (Filed With SEC on May 28, 2020)
- Amendment No. 1 to Distribution and License Agreement dated April 14, 2020 between Angionetics, Inc. and Shanxi Taxus Pharmaceuticals Co., Ltd (Filed With SEC on May 28, 2020)
- Distribution and License Agreement dated April 10, 2020 between Angionetics, Inc. and Shanxi Taxus Pharmaceuticals Co., Ltd (Filed With SEC on May 28, 2020)
- DISTRIBUTION AND LICENSE AGREEMENT (Filed With SEC on July 11, 2016)
- CUSTOM TECHNOLOGY ACCESS AND PRODUCT LICENSE AGREEMENT (Filed With SEC on November 22, 2010)
- SecondAmendment to the Exclusive License Agreement Between Yale University and Cardium Therapeutics, Inc. (Filed With SEC on October 26, 2005)
- Amendmentto License Agreement (Filed With SEC on October 26, 2005)
- Transfer, Consent to Transfer, Amendment and Assumption of License Agreement (Filed With SEC on October 26, 2005)
- Transfer, Consent to Transfer, Amendment and Assumption of License Agreement (Filed With SEC on October 26, 2005)
- Transfer, Consent to Transfer, Amendment and Assumption of License Agreement (Filed With SEC on October 26, 2005)
- Transfer, Consent to Transfer, Amendment and Assumption of License Agreement (Filed With SEC on October 26, 2005)
